|
(R)-1-[1-(4-acetoxy-3,3-dimethyl-2-oxo-butyl)-2-oxo-5-(pyridin-2-yl)-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl]-3-(3-methylamino-phenyl)-urea |
|---|---|
| Trade Name | |
| Orphan Indication | Gastro-entero-pancreatic neuroendocrine tumours |
| EU Market Approval | EU |
| EU Designation Date | 2015-12-14 00:00:00 |
| Sponsor | Trio Medicines Ltd |
